SBFM Sunshine Biopharma Inc.: institutional ownership and insider trading
8 funds reported holding $32.4K of Sunshine Biopharma Inc. in their latest 13F filings; in Q2 2026 funds net bought $31.1K, with 9 new positions and 0 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market; over its last four quarters it reported revenue of $35.3M and net income of −$5.83M.
SBFM revenue and earnings
- Quarter ended Jun 30, 2026: revenue $9.26M, net income −$1.56M
- Quarter ended Mar 31, 2026: revenue $8.09M, net income −$1.24M
- Quarter ended Dec 31, 2025: revenue $8.58M, net income −$2.14M
- Quarter ended Sep 30, 2025: revenue $9.42M, net income −$884K
Largest institutional holders of SBFM
- JANE STREET GROUP, LLC — $31.4K
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $808
- SBI Securities Co., Ltd. — $165
- NATIONAL BANK OF CANADA /FI/ — $10
- OSAIC HOLDINGS, INC. — $4
- Caitong International Asset Management Co., Ltd — $2
- Strive Financial Group ,LLC — $2
- TD Waterhouse Canada Inc. — $1
Members of Congress trading SBFM
- Jun 30, 2022: Roger Williams bought $1.00K–$15.0K
5%+ owners
- Mitchell P. Kopin: 10.0% (Schedule 13G/A, filed Aug 13, 2026)
- CVI Investments, Inc.: 9.9% (Schedule 13G, filed Oct 13, 2026)
- BJI Financial Group: 6.0% (Schedule 13G, filed Oct 14, 2026)
Who owns the most SBFM stock?
The largest institutional holders of Sunshine Biopharma Inc. in the latest 13F filings are JANE STREET GROUP, LLC ($31.4K), MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) ($808), SBI Securities Co., Ltd. ($165).
Are insiders buying or selling SBFM?
No open-market insider buys or sells of Sunshine Biopharma Inc. were reported in the last 12 months.
What was SBFM's revenue last quarter?
Sunshine Biopharma Inc. reported revenue of $9.26M for the quarter ended June 30, 2026, with net income of −$1.56M.